Invests in categories: Artificial IntelligenceDataDiagnosticsHardwareHealthTechITMedTechPersonalPlatformTechnology
Investment Type: Venture Capital
Portfolio 4
Persons 1
| Date | First Name | Last Name | Title | LinkedIn | Email |
| - | David | Gordon | Head of In... | linkedin.c... | d****g@lon... |
Mentions in press and media 4
| Date | Title | Description |
| 21.06.2022 | Apowiser Raises $1.5M In Seed Funding from Longliv Ventures, a Member of CK Hutchison Holdings, to Expand the Global Reach of its Novel Digital Platform that Empowers Consumers to make Informed Choice... | RA'ANANA, Israel, June 21, 2022 /PRNewswire/ -- Apowiser, an early-stage Israeli start-up that has developed PharmAssist, a chatbot-based system to support customers in the online purchase of Over-the-Counter (OTC) drugs announced today a $... |
| 05.08.2020 | Sight Diagnostics raises another $71M to fully commercialize its blood analyzer | “We have a specific focus on the U.S market and are planning to ramp up commercialization as allowed by FDA 510(k) clearance,” wrote Yossi Pollak, the company’s CEO in an email response to questions that was forwarded by a representative. “... |
| 05.08.2020 | Sight Diagnostics raises $71M Series D for its blood analyzer | Sight Diagnostics, the Israel-based health-tech company behind the FDA-cleared OLO blood analyzer, today announced that it has raised a $71 million Series D round with participation from Koch Disruptive Technologies, Longliv Ventures (which... |
| - | Sight Diagnostics raises another $71M to fully commercialize its blood analyzer | Tel Aviv, Israel-based Sight Diagnostics, which makes a complete blood count (CBC) analyzer only requiring two drops of blood, announced Wednesday that it had raised $71 million in a Series D funding round.
The investment comes from investo... |
Reviews 0
